BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35045645)

  • 21. Chronic hepatitis B: A wave of new therapies on the horizon.
    Block TM; Rawat S; Brosgart CL
    Antiviral Res; 2015 Sep; 121():69-81. PubMed ID: 26112647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term efficacy and safety of peginterferon in the treatment of children with HBeAg-positive chronic hepatitis B.
    Liu Y; Li H; Yan X; Wei J
    J Viral Hepat; 2019 Jul; 26 Suppl 1():69-76. PubMed ID: 31380585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New therapeutic agents for chronic hepatitis B.
    Brahmania M; Feld J; Arif A; Janssen HL
    Lancet Infect Dis; 2016 Feb; 16(2):e10-21. PubMed ID: 26795693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.
    Guo JT; Guo H
    Antiviral Res; 2015 Oct; 122():91-100. PubMed ID: 26272257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lamivudine therapy for chronic hepatitis B in children: a meta-analysis.
    Luo A; Jiang X; Ren H
    Virol J; 2019 Jul; 16(1):88. PubMed ID: 31272463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progress in diagnosis and treatment of viral hepatitis in children].
    Chang YN; Xu HM
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jan; 29(1):16-20. PubMed ID: 33541019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Natural History and Treatment Indications of Chronic Hepatitis B].
    Sinn DH
    Korean J Gastroenterol; 2019 Nov; 74(5):245-250. PubMed ID: 31765552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral antivirals for chronic hepatitis B.
    Min AD; Dienstag JL
    Clin Liver Dis; 2007 Nov; 11(4):851-68, ix. PubMed ID: 17981232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Monitoring and treatment strategy for chronic hepatitis B and antiviral resistant hepatitis B].
    Kim TY; Sohn JH
    Korean J Gastroenterol; 2007 Jun; 49(6):346-55. PubMed ID: 17641552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B: From control to cure.
    Kao JH
    J Formos Med Assoc; 2018 Oct; 117(10):868-870. PubMed ID: 30201191
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiviral therapy of chronic hepatitis B.
    Zoulim F
    Antiviral Res; 2006 Sep; 71(2-3):206-15. PubMed ID: 16716414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Another oral antiviral treatment, but still far away from hepatitis B virus cure.
    Tseng TC
    Clin Mol Hepatol; 2021 Apr; 27(2):281-282. PubMed ID: 33687857
    [No Abstract]   [Full Text] [Related]  

  • 34. New concepts regarding finite oral antiviral therapy for HBeAg-negative chronic hepatitis B.
    Papatheodoridi M; Papatheodoridis G
    J Hepatol; 2021 Dec; 75(6):1495-1496. PubMed ID: 34171438
    [No Abstract]   [Full Text] [Related]  

  • 35. Antiviral therapy of chronic hepatitis B: prevention of drug resistance.
    Fournier C; Zoulim F
    Clin Liver Dis; 2007 Nov; 11(4):869-92, ix. PubMed ID: 17981233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibiting the Secretion of Hepatitis B Surface Antigen (HBsAg) to Treat Hepatitis B Infection- a Review.
    Baugh SDP
    Infect Disord Drug Targets; 2017; 17(1):24-35. PubMed ID: 28056752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pursuit of anti-hepatitis B virus therapy].
    Xie W; Xu XY
    Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):577-581. PubMed ID: 31594074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy for Chronic Hepatitis B Virus Infection.
    Bertoletti A; Le Bert N
    Gut Liver; 2018 Sep; 12(5):497-507. PubMed ID: 29316747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study.
    Zhu S; Zhang H; Dong Y; Wang L; Xu Z; Liu W; Gan Y; Tang H; Chen D; Wang F; Zhao P
    J Hepatol; 2018 Jun; 68(6):1123-1128. PubMed ID: 29452204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of antiviral resistance and escape mutations in children with naive chronic hepatitis B patients and their parents.
    Tokgöz Y; Terlemez S; Sayan M; Kırdar S
    Turk J Pediatr; 2018; 60(5):514-519. PubMed ID: 30968634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.